The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease

被引:147
|
作者
Hastings, Teresa G. [1 ,2 ]
机构
[1] Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Dept Neurol, Sch Med, Pittsburgh, PA 15261 USA
关键词
Parkinson's disease; Mitochondria; Dopamine quinone; Oxidative stress; RAT-BRAIN MITOCHONDRIA; ALPHA-SYNUCLEIN; PERMEABILITY TRANSITION; NEURODEGENERATION; STRESS; CELLS; IDENTIFICATION; MECHANISMS; MORPHOLOGY; AUTOPHAGY;
D O I
10.1007/s10863-009-9257-z
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The etiology of sporadic Parkinson's disease (PD) is unknown, although mitochondrial dysfunction and oxidative stress have been implicated in the mechanisms associated with PD pathogenesis. Dopamine (DA) neurons of the substantia nigra pars compacta have been shown to degenerate to a greater extent in PD than other neurons suggesting the possibility that DA itself may be contributing to the neurodegenerative process. This review discusses our work on the effects of DA oxidation and reactive DA quinones on mitochondrial function and protein modification and the potential for exacerbating toxicity associated with mitochondrial dysfunction in PD.
引用
收藏
页码:469 / 472
页数:4
相关论文
共 50 条
  • [1] The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson’s disease
    Teresa G. Hastings
    [J]. Journal of Bioenergetics and Biomembranes, 2009, 41 : 469 - 472
  • [2] Mitochondrial dysfunction mediated by quinone oxidation products of dopamine: Implications in dopamine cytotoxicity and pathogenesis of Parkinson's disease
    Jana, Sirsendu
    Sinha, Maitrayee
    Chanda, Dalia
    Roy, Tapasi
    Banerjee, Kalpita
    Munshi, Soumyabrata
    Patro, Birija S.
    Chakrabarti, Sasanka
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2011, 1812 (06): : 663 - 673
  • [3] Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease
    Burbulla, Lena F.
    Song, Pingping
    Mazzulli, Joseph R.
    Zampese, Enrico
    Wong, Yvette C.
    Jeon, Sohee
    Santos, David P.
    Blanz, Judith
    Obermaier, Carolin D.
    Strojny, Chelsee
    Savas, Jeffrey N.
    Kiskinis, Evangelos
    Zhuang, Xiaoxi
    Kruger, Rejko
    Surmeier, D. James
    Krainc, Dimitri
    [J]. SCIENCE, 2017, 357 (6357) : 1255 - +
  • [4] Role of mitochondrial dysfunction in Parkinson's disease - Implications for treatment
    Ramsey, Chenere P.
    Giasson, Benoit I.
    [J]. DRUGS & AGING, 2007, 24 (02) : 95 - 105
  • [5] Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson's Disease?
    Bantle, Collin M.
    Hirst, Warren D.
    Weihofen, Andreas
    Shlevkov, Evgeny
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 8
  • [7] Oxidation of 4-methyleatechol: Implications for dopamine oxidation and Parkinson's disease
    Li, GL
    Zhang, HD
    Njus, D
    [J]. FASEB JOURNAL, 2006, 20 (05): : A974 - A974
  • [8] Implications of p53 in mitochondrial dysfunction and Parkinson's disease
    Wang, Yi-Fan
    Wang, Ying-Di
    Gao, Song
    Sun, Wei
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2024, 134 (08) : 906 - 917
  • [9] Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: Implications for Parkinson's disease
    Berman, SB
    Hastings, TG
    [J]. JOURNAL OF NEUROCHEMISTRY, 1999, 73 (03) : 1127 - 1137
  • [10] Mitochondrial dysfunction in Parkinson's disease
    Fukae, Jiro
    Mizuno, Yoshikuni
    Hattori, Nobutaka
    [J]. MITOCHONDRION, 2007, 7 (1-2) : 58 - 62